Evolution of the Average Target: Amarin Corporation plc

Evolution of the Average Target - Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Evolution of the Target Price - Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

d5d5c64a.B8A70fEqRAr3gUNwnKJagZRNj5DxQZOCVtPPLILt0Ig.SItM_Jp8CTixzzU-z-gc1fIf_PioMtTxA7ufZvGlk71osAvioUw1f5TSDg~8c0357c2f7b7791dcc6790e483a09640
25-10-27 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25-06-25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
23-10-25 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
23-07-19 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
23-01-06 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
22-10-19 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
22-05-06 JPMorgan Downgrades Amarin to Underweight From Neutral MT
22-05-05 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
22-05-05 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
22-05-05 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
22-02-16 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
22-01-31 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
21-05-12 Amarin : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
21-02-01 Amarin : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
20-12-23 Amarin : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
20-12-07 Amarin : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- +8.41%
+30.97%
+13.23%
+38.42%
+13.19%
+17.91%
+41.56%
+35.14%
+24.78%
+9.2%
Average +23.28%
Weighted average by Cap. +25.73%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
11.53USD
Average target price
12.50USD
Spread / Average Target
+8.41%
High Price Target
13.00USD
Spread / Highest target
+12.75%
Low Price Target
12.00USD
Spread / Lowest Target
+4.08%

Analyst Consensus Detail

Analyst consensus - Amarin Corporation plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Amarin Corporation plc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Amarin Corporation plc
  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc